Neurovalens raises £5 million for clinical trials of its neurostimulation tech

The funding will aim to facilitate the company ’s technology to treat conditions such as diabetes, insomnia, anxiety and obesity.
Source: mobihealthnews - Category: Information Technology Source Type: news